Skip to main content
Decorative image of the Sepsis Learning Lounge

Viewpoints Series: Enhancing Sepsis Care Across the Patient Journey 

SUMMARY

Learning Lounge Exclusive | January 2025 A recent survey by bioMérieux and The UK Sepsis Trust found that while 95% of clinicians identify sepsis as a serious condition, 66% agree there is sometimes a delay in diagnosis in the hospital where they work.

In this exclusive Viewpoints Series interview, intensivist Julien Textoris, MD, PhD, shares thought provoking insights about enhancing sepsis care across the patient journey, and offers his relatable perspective on the critical need for early recognition, diagnosis, and care.

The interview explores:

  • The impact of prompt antimicrobial administration on sepsis patient outcomes.
  • The role of technological innovations in supporting clinicians to monitor at-risk sepsis patients and implement time-sensitive treatment protocols.

FEATURED EXPERT    

Julien Textoris, MD, PhD, Vice President - EMEA Medical Affairs, bioMérieux


GET STARTED

Unlock essential insights into the critical need for enhancing sepsis care.

Learn More

Filename
LL-Viewpoints-Series_Enhancing-Sepsis-Care-Across-the-Patient-Journey---Julien-Textoris_January-2025.pdf
Size
521 KB
Format
application/pdf

Estimated reading time: 4 minutes


We want to hear from you!

Your feedback helps us continue to provide resources and content specific to your needs.


U.S. bioMérieux Solutions

YOU MAY ALSO LIKE

Explore how low adherence to sepsis care guidelines puts patients at risk. 

Download this bonus infographic today!

Global Solutions

GLOBAL SEPSIS SOLUTIONS

PCT biomarker testing helps differentiate bacterial from viral infections and supports clinicians in the early diagnosis of sepsis. Learn more about bioMérieux’s VIDAS® B•R•A•H•M•S PCT™ assay. 

PUBLISHED BY

Learning Lounge Exclusive

September 5, 2023


SHARE THIS ARTICLE: